Neurodegenerative diseases: from gut-brain axis to brain microbiome.
作者信息
Friedland Robert P, Haribabu Bodduluri
机构信息
Department of Neurology, University of Louisville School of Medicine, Louisville, KY, United States.
Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, United States.
出版信息
Front Aging Neurosci. 2023 May 19;15:1171955. doi: 10.3389/fnagi.2023.1171955. eCollection 2023.
Abstract
摘要
相似文献
1
Neurodegenerative diseases: from gut-brain axis to brain microbiome.神经退行性疾病：从肠-脑轴到脑微生物群
Front Aging Neurosci. 2023 May 19;15:1171955. doi: 10.3389/fnagi.2023.1171955. eCollection 2023.
2
A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.脑-肠-微生物轴综述及微生物群在阿尔茨海默病中的潜在作用。
J Alzheimers Dis. 2020;73(3):849-865. doi: 10.3233/JAD-190872.
3
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer's Disease.肠道微生物群和微生物代谢产物在阿尔茨海默病发病机制中的作用
CNS Neurol Disord Drug Targets. 2023;22(4):577-598. doi: 10.2174/1871527321666220417005115.
5
Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases.将昼夜节律与衰老相关神经退行性疾病中的微生物群-肠-脑轴联系起来。
Ageing Res Rev. 2022 Jun;78:101620. doi: 10.1016/j.arr.2022.101620. Epub 2022 Apr 8.
6
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.肠道微生物群在神经炎症和神经退行性变中的调节作用的新出现，重点是阿尔茨海默病。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110112. doi: 10.1016/j.pnpbp.2020.110112. Epub 2020 Sep 16.
7
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.微生物群-脑-肠轴与神经退行性疾病。
Curr Neurol Neurosci Rep. 2017 Oct 17;17(12):94. doi: 10.1007/s11910-017-0802-6.
8
Gut microbiota and pro/prebiotics in Alzheimer's disease.肠道微生物群和阿尔茨海默病的益生菌/益生元。
Aging (Albany NY). 2020 Mar 19;12(6):5539-5550. doi: 10.18632/aging.102930.
9
Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.直接调节肠道微生物群作为治疗阿尔茨海默病的一种方法。
CNS Neurol Disord Drug Targets. 2022;21(1):14-25. doi: 10.2174/1871527320666210806165751.
10
Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.慢性噪声暴露对衰老加速敏感小鼠微生物群-肠-脑轴的影响：对阿尔茨海默病的启示。
J Neuroinflammation. 2018 Jun 22;15(1):190. doi: 10.1186/s12974-018-1223-4.
引用本文的文献
1
The microbial guardians: Unveiling the role of gut microbiota in shaping neurodegenerative disease.微生物守护者：揭示肠道微生物群在神经退行性疾病形成中的作用。
IBRO Neurosci Rep. 2025 May 30;19:17-37. doi: 10.1016/j.ibneur.2025.05.014. eCollection 2025 Dec.
2
The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases.肠道微生物群和饮食作为阿尔茨海默病和帕金森病病程调节因素的作用
Nutrients. 2024 Jan 19;16(2):308. doi: 10.3390/nu16020308.
本文引用的文献
1
Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS.产突变体和卷曲菌的大肠杆菌增强了 ALS 模型小鼠 hSOD1-G93A 中的疾病表型。
Sci Rep. 2023 Apr 12;13(1):5945. doi: 10.1038/s41598-023-32594-5.
2
Editorial: Neurodegenerative diseases: From gut-brain axis to brain microbiome.社论：神经退行性疾病：从肠-脑轴到脑微生物群
Front Aging Neurosci. 2022 Oct 12;14:1052805. doi: 10.3389/fnagi.2022.1052805. eCollection 2022.
3
Gut microbiome-mediated regulation of neuroinflammation.肠道微生物群介导的神经炎症调节。
Curr Opin Immunol. 2022 Jun;76:102177. doi: 10.1016/j.coi.2022.102177. Epub 2022 Apr 21.
4
Inflammasome activation in neurodegenerative diseases.炎症小体在神经退行性疾病中的激活作用。
Essays Biochem. 2021 Dec 22;65(7):885-904. doi: 10.1042/EBC20210021.
5
Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration.全基因组筛选发现卷曲菌纤维状淀粉样蛋白是促进宿主神经退行性变的细菌成分。
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2106504118.
6
Identification of amyloidogenic proteins in the microbiomes of a rat Parkinson's disease model and wild-type rats.鉴定帕金森病大鼠模型和野生型大鼠微生物组中的淀粉样蛋白原性蛋白。
Protein Sci. 2021 Sep;30(9):1854-1870. doi: 10.1002/pro.4137. Epub 2021 Jun 9.
7
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.抑制微生物群依赖的 TMAO 生成可减轻小鼠慢性肾脏病。
Sci Rep. 2021 Jan 12;11(1):518. doi: 10.1038/s41598-020-80063-0.
8
Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives.阿尔茨海默病中断的疾病修饰疗法：现状与未来展望。
Expert Opin Investig Drugs. 2020 Sep;29(9):919-933. doi: 10.1080/13543784.2020.1795127. Epub 2020 Jul 26.
9
A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice.肠道细菌淀粉样蛋白促进小鼠α-突触核蛋白聚集和运动障碍。
Elife. 2020 Feb 11;9:e53111. doi: 10.7554/eLife.53111.
10
Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents.结构洞察卷曲菌 CsgA 交叉-β 纤维结构，启发抗淀粉样化合物重新用作抗生物膜剂。
PLoS Pathog. 2019 Aug 30;15(8):e1007978. doi: 10.1371/journal.ppat.1007978. eCollection 2019 Aug.
Zotero 插件